Risk Factors of Hyperammonemia in Patients with Epilepsy Under Valproic Acid Therapy
Medicine 93:e66, Tseng, Y.L.,et al, 2014
Valproate-Induced Hyperammonemic Encephalopathy in the Presence of Topiramate
Neurol 54:230-232, Hamer,H.M.,et al, 2000
Clumsiness, Confusion, Coma, and Valproate
Lancet 353:1408, Ellaway,C.J.,et al, 1999
Valproic Acid-Induced Hyperammonemic Encephalopathy:MR Appearance
AJNR 15:1779-1781, Baganz,M.D.&Dross,P.E., 1994
A 22-year-old Man Presenting with Headache and Right Leg Jerks
Neurol 91:891-895, Schupper, A.J.,et al, 2018
Effects of Fetal Antiepileptic Drug Exposure
Neurol 78:1207-1214, Meador,K.J.,et al, 2012
Cognitive Function at 3 Years of Age After Fetal Exposure to Antiepileptic Drugs
NEJM 360:1597-1605,1667, Meador,K.J.,et al, 2009
Valproic Acid Adjunctive Therapy for HIV-Associated Cognitive Impairment: A First Report
Neurol 66:919-921, Schifitto,G.,et al, 2006
Effects of Oxcarbazepine on Cognitive Function in Children and Adolescents with Partial Seizures
Neurol 67:679-682, Donati,F.,et al, 2006
Neuropsychological Effects of Exposure to Anticonvulsant Medication in Utero
Neurol 64:949-954, 938, Vinten,J., et al, 2005
Normal Intelligence in Children with Prenatal Exposure to Carbamazepine
Neurol 62:28-32,8, Gaily,E.,et al, 2004
Reversible Parkinsonism and Cognitive Impairment with Chronic Valproate Use
Neurol 47:626-635, Armon,C.,et al, 1996
Comparative Cognitive Effects of Phenobarbital, Phenytoin, and Valproate in Healthy Adults
Neurol 45:1494-1499, Meador,K.J.,et al, 1995
Withdrawal of Antiepileptic Medication in Children-Effects of Congit Funct Multicenter Holmfrid Study
Aldenkamp. A. P. , et al, neurol 43:41-50., , 1993
Valproic Acid for the Treatment of Children with Mental Retardation and Mood Symptomatology
Pediatrics 86:467-472, Kastner,T.,et al, 1990
Valproate-Induced Coma with Ketosis and Carnitine Insufficiency
Arch Neurol 47:1131-1133, Triggs,W.J.,et al, 1990
Psychologic & Behavioral Effects of Antiepileptic Drugs in Children:Comparison of Phenobarb & Valproic Acid
Pediatrics 80:165-174, Vining,E.P.G.,et al, 1987
Choosing Anticonvulsant Medications to Manage Status Epilepticus
NEJM 382:2569-2572, Wu, K., 2020
Randomized Trial of Three Anticonvulsant Medications for Status Epilepticus
NEJM 381:2103-2113,2171, Kapur, J.,et al, 2019
Clinicopathologic Conference, Copper Deficiency Myelopathy
NEJM 377:1977-1984, Case 35-2017, 2017
Randomized Study of Intravenous Valproate and Phenytoin in Status Epilepticus
Seizure 16:527-532, Agarwal,P.,et al, 2007
Intravenous Sodium Valproate Versus Diazepam Infusion for the Control of Refractory Status Epilepticus in Children: A Randomized Controlled Trial
J Child Neurol 22:1191-1197, Mehta,V.,et al, 2007
Sodium Valproate vs Phenytoin in Status Epilepticus: A Pilot Study
Neurol 67:340-342, Misra,U.K.,et al, 2006
Efficacy of rapid IV administration of valproic acid for status epilepticus
Neurol 64:353-355, Limdi, N.A., et al, 2005
Major Malformations in Offspring of Women with Epilepsy
Neurol 60:575-579, Kaaja,E.,et al, 2003
Intravenous Valproic Acid for Myoclonic Status Epilepticus
Neurol 54:1201, Sheth,R.D. & Gidal,B.E., 2000
Intravenous Valproate in Pediatric Epilepsy Patients with Refractory Status Epilepticus
Neurol 54:2188-2189, Uberall,M.A.,et al, 2000
Intravenous Valproate is Well Tolerated in Unstable Patients with Status Epilepticus
Neurol 55:722-724, Sinha,S. & Naritoku,D.K., 2000
Treatment of Absence Status with Intravenous Valproate
Neurol 52:889-890, Alehan,F.K.,et al, 1999
Status Epilepticus
NEJM 338:970-976, Lowenstein,D.H.&Alldredge,B.K., 1998
Antiepileptics and Blood Dyscrasias: A Cohort Study
Pharmacotherapy 18:1277-1283, Blackburn,S.C.F.,et al, 1998
Safety of Intravenous Valproate
Ann Neurol 38:670-674, Devinsky,O.,et al, 1995
Reversible Dementia and Apparent Brain Atrophy During Valproate Therapy
Ann Neurol 38:687-691, Papazian,O.,et al, 1995
Early Childhood Hepatocerebral Degeneration Misdiagnosed as Valproate Hepatotoxicity
Ann Neurol 32:767-775, Bicknese,A.R.,et al, 1992
Typical Absence Seizures in Adults:Clinical, EEG, Video-EEG Findings & Diagnostic/Syndr Consider
JNNP 55:1002-1008, Panayiotopoulos,C.P.,et al, 1992
Valproate Prevents the Recurrence of Absence Status
Neurol 39:1294-1297, Berkovic,S.F.,et al, 1989
Improvement in Cognitive Functioning and Mood State After Conversion to Valproate Monotherapy
Neurol 39:1640-1641, Prevey,M.L.,et al, 1989
Clinical Valproate Toxicity Induced by Acetylsalicylic Acid
Neurol 37:1392-1394, Goulden,K.J.,et al, 1987
Valproate-Ethosuximide Combination Therapy for Refractory Absence Seizures
Arch Neurol 40:797-802, Rowan,A.J.,et al, 1983
Valproic Acid
NEJM 302:661-666, Brown,T.R., 1980
Rectal Valproate Syrup & Status Epilepticus
Neurol 30:1113-1114, Thorpy,M.J., 1980
Interaction Between Clonazepam & Sodium Valproate
NEJM 300:678-679, Watson,W.A., 1979
Treatment of Accidental Sodium Valproate Overdose with an Opiate Antagonist
Ann Neurol 6:274, Steiman,G.S.,et al, 1979
Rectal Administration of Sodium Valproate in Status Epilepticus
Neurol 28:897-899, Vajda,F.J.E.,et al, 1978
Antiepileptic Drug Treatment Patterns in Women of Childbearing Age with Epilepsy
JAMA Neurol 76:783-790, Kim, H.,et al, 2019
Risk of 23 Specific Malformations Associated with Prenatal Exposure to 10 Antiepileptic Drugs
Neurol 93:e167-e180, Blotiere, P.O.,et al, 2019
Declining Malformation Rates with Changed Antiepileptic Drug Prescribing, An Observational Study
Neurol 93:e831-e840, Tomson,T.,et al, 2019
Maternal Use of antiepileptic Agents During Pregnancy and Major Congenital Malformations in Children
JAMA 318:1700-1701, Bromley, R.L.,et al, 2017
Fetal Effects of Anticonvulsant Polytherapies
Arch Neurol 68:1273-1279, Holmes, L.et al, 2011